Literature DB >> 17638078

Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Gil Weitzman1, Neil J Schamberg, Gerond Lake-Bakaar.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17638078     DOI： 10.1007/s10620-006-9371-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  40 in total

1.  Treatment of hepatic encephalopathy.

Authors:  Juan Córdoba; Beatriz Mínguez; Mercedes Vergara
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

2.  Hepatic infarction: unusual complication of a transjugular intrahepatic portosystemic shunt.

Authors:  R Sawhney; S D Wall; J Yee; I Hayward
Journal:  J Vasc Interv Radiol       Date:  1997 Jan-Feb       Impact factor: 3.464

Review 3.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  Splenectomy in myeloid metaplasia.

Authors:  M N Silverstein; W H ReMine
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

5.  Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.

Authors:  T Kawasaki; A Takeshita; K Souda; Y Kobayashi; M Kikuyama; F Suzuki; F Kageyama; Y Sasada; E Shimizu; G Murohisa; S Koide; T Yoshimi; H Nakamura; R Ohno
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

6.  Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.

Authors:  Jian-Gao Fan; Zheng-Jie Xu; Guo-Liang Wang
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 7.  Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure.

Authors:  H Mayan; R Kantor; U Rimon; N Golubev; Z Heyman; E Goshen; B Shalmon; P Weiss
Journal:  Liver       Date:  2001-10

8.  Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.

Authors:  G Akpek; D McAneny; L Weintraub
Journal:  J Surg Oncol       Date:  2001-05       Impact factor: 3.454

9.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

10.  Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Authors:  A J Sanyal; A M Freedman; M L Shiffman; P P Purdum; V A Luketic; A K Cheatham
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425
View more
  2 in total

Review 1.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

2.  Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.

Authors:  Lei Wang; Zhibo Xiao; Zhendong Yue; Hongwei Zhao; Zhenhua Fan; Mengfei Zhao; Fuliang He; Shan Dai; Bin Qiu; Jiannan Yao; Qiushi Lin; Xiaoqun Dong; Fuquan Liu
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.